{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:19:10Z","timestamp":1771949950407,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.eurox.2019.100072","type":"journal-article","created":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T09:33:23Z","timestamp":1560677603000},"page":"100072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Use of antenatal fluorinated corticosteroids in management of congenital heart block: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"4","author":[{"given":"Armia","family":"Michael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad A.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Kamel","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Yassien","family":"Abd-Elkariem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif A.","family":"Shazly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.eurox.2019.100072_bib0005","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.hlc.2012.05.784","article-title":"Congenital complete heart block: single tertiary centre experience","volume":"21","author":"Yan","year":"2012","journal-title":"Heart Lung Circ"},{"issue":"5","key":"10.1016\/j.eurox.2019.100072_bib0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.eurox.2019.100072_bib0015","first-page":"126","article-title":"Pregnancy with SLE and fetal congenital heart block: a case report","volume":"4","author":"Puri","year":"2013","journal-title":"Cardiol Res"},{"issue":"8","key":"10.1016\/j.eurox.2019.100072_bib0020","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti\u2010Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.eurox.2019.100072_bib0025","first-page":"180","article-title":"Isolated congenital heart block in undifferentiated connective tissue disease and in primary Sj\u00f6gren\u2019s syndrome: a clinical study of 81 pregnancies in 41 patients","volume":"57","author":"Grava","year":"2005","journal-title":"Reumatismo"},{"issue":"10","key":"10.1016\/j.eurox.2019.100072_bib0030","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/art.1780291013","article-title":"Anti\u2010SS\u2010a antibodies and fetal outcome in maternal systemic lupus erythematosus","volume":"29","author":"Ramsey\u2010Goldman","year":"1986","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.eurox.2019.100072_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi\u2013racial\/ethnic registry of anti-SSA\/Ro\u2013associated cardiac neonatal lupus","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.eurox.2019.100072_bib0040","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1046\/j.1460-9592.2002.01685.x","article-title":"Pacemaker therapy in isolated congenital complete atrioventricular block","volume":"25","author":"Breur","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.eurox.2019.100072_bib0045","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/j.1540-8159.2008.00948.x","article-title":"Indications for pacing in patients with congenital heart disease","volume":"31","author":"Villain","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.eurox.2019.100072_bib0050","first-page":"36","article-title":"A review of congenital heart block","volume":"5","author":"Friedman","year":"2003","journal-title":"Images Paediatr Cardiol"},{"key":"10.1016\/j.eurox.2019.100072_bib0055","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"GA W","year":"2000","journal-title":"3rd Symposium on Systematic Reviews: Beyond the Basics"},{"issue":"3","key":"10.1016\/j.eurox.2019.100072_bib0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"11","key":"10.1016\/j.eurox.2019.100072_bib0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta\u2010analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.eurox.2019.100072_bib0070","series-title":"Review manager (RevMan) [computer program] Version 53","author":"Collaboration, N.C.C.T.C","year":"2014"},{"issue":"2","key":"10.1016\/j.eurox.2019.100072_bib0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/096120339500400207","article-title":"In utero identification and therapy of congenital heart block","volume":"4","author":"Buyon","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.eurox.2019.100072_bib0080","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.eurox.2019.100072_bib0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1017\/S1047951109004053","article-title":"The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block","volume":"19","author":"Fesslova","year":"2009","journal-title":"Cardiol Young"},{"issue":"24","key":"10.1016\/j.eurox.2019.100072_bib0090","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","article-title":"The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: a prospective study of 186 antibody-exposed fetuses and infants","volume":"55","author":"Jaeggi","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.eurox.2019.100072_bib0095","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.eurox.2019.100072_bib0100","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/pd.4547","article-title":"Clinical course and outcome of antenatally detected atrioventricular block: experience of a single tertiary centre and review of the literature","volume":"35","author":"Kuleva","year":"2015","journal-title":"Prenat Diagn"},{"issue":"12","key":"10.1016\/j.eurox.2019.100072_bib0105","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.autrev.2015.08.005","article-title":"Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome","volume":"14","author":"Levesque","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.eurox.2019.100072_bib0110","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCULATIONAHA.107.735118","article-title":"Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution","volume":"118","author":"Lopes","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.eurox.2019.100072_bib0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1253\/circj.CJ-11-1020","article-title":"Evaluation of transplacental treatment for fetal congenital bradyarrhythmia","volume":"76","author":"Miyoshi","year":"2012","journal-title":"Circ J"},{"issue":"5","key":"10.1016\/j.eurox.2019.100072_bib0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.anpede.2013.12.004","article-title":"Foetal bradycardia: a retrospective study in 9 Spanish centres","volume":"81","author":"Per\u00edn","year":"2014","journal-title":"Anales de Pediatr\u00eda (English Edition)"},{"issue":"11","key":"10.1016\/j.eurox.2019.100072_bib0125","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody\u2010associated congenital heart block: retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.eurox.2019.100072_bib0130","first-page":"952","article-title":"Neonatal lupus erythematosus: results of maternal corticosteroid therapy","volume":"93","author":"Shinohara","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.eurox.2019.100072_bib0135","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2010.09.044","article-title":"Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy","volume":"57","author":"Trucco","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eurox.2019.100072_bib0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2016.09.119","article-title":"Fluorinated steroids do not improve outcome of isolated atrioventricular block","volume":"225","author":"Van den Berg","year":"2016","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.eurox.2019.100072_bib0145","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2015-208311","article-title":"Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system","volume":"75","author":"Izmirly","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"10.1016\/j.eurox.2019.100072_bib0150","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.cir.0000437597.44550.5d","article-title":"Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association","volume":"129","author":"Donofrio","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.eurox.2019.100072_bib0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrcardio.2010.32","article-title":"Fetal cardiac arrhythmia detection and in utero therapy","volume":"7","author":"Strasburger","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.eurox.2019.100072_bib0160","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.amjcard.2007.03.081","article-title":"Atrial and ventricular rate response and patterns of heart rate acceleration during maternal-fetal terbutaline treatment of fetal complete heart block","volume":"100","author":"Cuneo","year":"2007","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.eurox.2019.100072_bib0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jsha.2014.07.001","article-title":"Atrioventricular block during fetal life","volume":"27","author":"Hunter","year":"2015","journal-title":"J Saudi Heart Assoc"},{"issue":"6","key":"10.1016\/j.eurox.2019.100072_bib0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CRD.0000000000000026","article-title":"Prevention and treatment in utero of autoimmune-associated congenital heart block","volume":"22","author":"Saxena","year":"2014","journal-title":"Cardiol Rev"},{"issue":"4","key":"10.1016\/j.eurox.2019.100072_bib0175","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.eurox.2019.100072_bib0180","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.eurox.2019.100072_bib0185","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/art.22157","article-title":"Antimalarial agents: closing the gate on Toll-like receptors?","volume":"54","author":"Lafyatis","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"35","key":"10.1016\/j.eurox.2019.100072_bib0190","doi-asserted-by":"crossref","first-page":"30444","DOI":"10.1074\/jbc.M111.263657","article-title":"A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block","volume":"286","author":"Alvarez","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.eurox.2019.100072_bib0195","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.eurox.2019.100072_bib0200","first-page":"67","article-title":"Sj\u00f6gren\u2019s syndrome diagnosed in pregnancy: a case report","volume":"50","author":"Aslan","year":"2005","journal-title":"J Reprod Med"},{"issue":"5","key":"10.1016\/j.eurox.2019.100072_bib0205","first-page":"365","article-title":"Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjogren\u2019s syndrome A\/Ro antibody","volume":"38","author":"Yang","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"10.1016\/j.eurox.2019.100072_bib0210","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/uog.1713","article-title":"Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature","volume":"24","author":"Breur","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.eurox.2019.100072_bib0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/art.1780350209","article-title":"Anti\u2014Ro\/SS\u2010a antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model","volume":"35","author":"Alexander","year":"1992","journal-title":"Arthritis & Rheum"},{"issue":"20","key":"10.1016\/j.eurox.2019.100072_bib0220","article-title":"Maternal connective-tissue disease and congenital heart-block","volume":"312","author":"Herreman","year":"1985","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eurox.2019.100072_bib0225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJM198501103120206","article-title":"Maternal connective tissue disease and congenital heart block: demonstration of immunoglobulin in cardiac tissue","volume":"312","author":"Litsey","year":"1985","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eurox.2019.100072_bib0230","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0002-9343(87)90918-1","article-title":"Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies","volume":"83","author":"Lee","year":"1987","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.eurox.2019.100072_bib0235","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/eje.0.1440087","article-title":"Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues","volume":"144","author":"Quinkler","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eurox.2019.100072_bib0240","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0029-7844(98)00149-5","article-title":"A new therapeutic approach to the fetus with congenital complete heart block: preemptive, targeted therapy with dexamethasone","volume":"92","author":"Rosenthal","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.eurox.2019.100072_bib0245","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3109\/14767051003728237","article-title":"A management strategy for fetal immune-mediated atrioventricular block","volume":"23","author":"Cuneo","year":"2010","journal-title":"J Matern Neonatal Med"},{"issue":"12","key":"10.1016\/j.eurox.2019.100072_bib0250","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.eurox.2019.100072_bib0255","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/0002-9378(95)90621-5","article-title":"Successful in utero therapy of fetal heart block","volume":"173","author":"Copel","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.eurox.2019.100072_bib0260","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.eurox.2019.100072_bib0265","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/aogs.13338","article-title":"Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: a systematic review and meta-analysis","volume":"97","author":"Ciardulli","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"10.1016\/j.eurox.2019.100072_bib0270","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody\u2010associated congenital heart block: retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.eurox.2019.100072_bib0275","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.1780330502","article-title":"Congenital complete heart block","volume":"33","author":"Buyon","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.eurox.2019.100072_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2017.09.005","article-title":"Should we treat congenital heart block with fluorinated corticosteroids?","author":"Brucato","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.eurox.2019.100072_bib0285","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/hrt.2005.069369","article-title":"Rhythm abnormalities of the fetus","volume":"93","author":"Hornberger","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.eurox.2019.100072_bib0290","first-page":"1","article-title":"Maternal steroid therapy for fetuses with immune-mediated complete atrioventricular block: a systematic review and meta-analysis","author":"Ciardulli","year":"2017","journal-title":"J Matern Neonatal Med"},{"issue":"11","key":"10.1016\/j.eurox.2019.100072_bib0295","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1136\/ard.2005.049866","article-title":"Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero","volume":"65","author":"Brucato","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.eurox.2019.100072_bib0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00246-008-9273-5","article-title":"Outcome of prenatally diagnosed isolated congenital complete atrioventricular block treated with transplacental betamethasone or ritodrine therapy","volume":"30","author":"Hayashi","year":"2009","journal-title":"Pediatr Cardiol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259016131930105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259016131930105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:57:02Z","timestamp":1762916222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259016131930105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":60,"alternative-id":["S259016131930105X"],"URL":"https:\/\/doi.org\/10.1016\/j.eurox.2019.100072","relation":{},"ISSN":["2590-1613"],"issn-type":[{"value":"2590-1613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of antenatal fluorinated corticosteroids in management of congenital heart block: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurox.2019.100072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100072"}}